Has Douglas Chan received payments from drug or device companies?

Yes. Drug and device makers reported $3,614 in general payments to Douglas Chan across 157 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Chan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Chan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Chan

Child & Adolescent Psychiatry · Atlanta, GANPI 1548558984

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.

$3,614in general payments, 2019–2025

Across 157 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$785
Supernus Pharmaceuticals, Inc.$539
Tris Pharma Inc$410
Otsuka America Pharmaceutical, Inc.$270
Lundbeck LLC$233
Bausch Health US, LLC$197
plus $1K from 15 others

What the payments were for

Food & beverage$3,614100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	32	$785
Supernus Pharmaceuticals, Inc.	13	$539
Tris Pharma Inc	19	$410
Otsuka America Pharmaceutical, Inc.	13	$270
Lundbeck LLC	12	$233
Bausch Health US, LLC	10	$197
Johnson & Johnson	8	$191
Corium, LLC	11	$167
Ironshore Pharmaceuticals Inc.	6	$140
Collegium Pharmaceutical, Inc.	8	$136
Takeda Pharmaceuticals U.S.A., Inc.	5	$109
AbbVie	3	$86
Idorsia Pharmaceuticals US Inc	4	$70
Noven Therapeutics, LLC	3	$69
Brainsway USA Inc	1	$43
Teva Pharmaceuticals USA, Inc.	3	$43
Noven Pharmaceuticals, Inc.	2	$37
Axsome Therapeutics, Inc.	1	$33
Tempus AI, Inc	1	$24
Neos Therapeutics, LP	1	$17
Vanda Pharmaceuticals Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$292

How this compares

$3,614 in reported general payments places this provider in the 85th percentile of 91 child & adolescent psychiatry providers in Georgia.

See all child & adolescent psychiatry providers in Georgia →

Other child & adolescent psychiatry in Atlanta

Suneel KatragaddaAtlanta$460K
Olujimi AdefisanAtlanta$14K
Mhd AlkhatibAtlanta$7K
Mary HuberAtlanta$7K
Jane LanierAtlanta$3K
Satyanarayana GedelaAtlanta$3K
Ericka GoodwinAtlanta$1K
Kerry SheahanAtlanta$1K
Debora JohnsonAtlanta$695
Melanie PointerAtlanta$669

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →